Key result
Post-extrasystolic potentiation boosts contractility ~81% in isolated end-stage HF myocardium versus frequency potentiation.
Why the study?
Does post-extrasystolic potentiation improve myocardial contractility compared to frequency potentiation in isolated working myocardium from patients with end-stage heart failure?
Does post-extrasystolic potentiation improve myocardial contractility compared to frequency potentiation in isolated working myocardium from patients with end-stage heart failure?
Absolute Event Rate: 81% vs 3%
Post-extrasystolic potentiation preserves its ability to augment myocardial contractility in end-stage heart failure, unlike frequency potentiation, suggesting potential as a therapeutic modality or indicator of contractile reserve.
No takes yet. Share an insight, caveat, or question.
PESP preserves inotropic reserve in end-stage HF myocardium; leaves open its utility as a reserve marker or therapeutic target.
Phillips et al. (1990) studied End-stage heart failure (n=27). Post-extrasystolic potentiation (PESP) vs. Frequency potentiation (FP) was evaluated on Augmentation of cardiac contractile performance in heart failure myocardium. In isolated myocardium from patients with end-stage heart failure, post-extrasystolic potentiation augmented contractility by 81% compared to only 3% with frequency potentiation.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: